|
DE2951135A1
(de)
|
1979-12-19 |
1981-06-25 |
Hoechst Ag, 6230 Frankfurt |
Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
|
|
US4889861A
(en)
|
1982-12-21 |
1989-12-26 |
Ciba-Geigy Corp. |
Substituted imidazo[1,5-a]pyridine derivatives and other substituted bicyclic derivatives and their use as aromatase inhibitors
|
|
US4617307A
(en)
|
1984-06-20 |
1986-10-14 |
Ciba-Geigy Corporation |
Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
|
|
DE3347565A1
(de)
|
1983-12-30 |
1985-07-11 |
Thomae Gmbh Dr K |
Neue phenylessigsaeurederivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
JPS6354321A
(ja)
|
1985-03-27 |
1988-03-08 |
Ajinomoto Co Inc |
血糖降下剤
|
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
ATE164852T1
(de)
|
1990-01-24 |
1998-04-15 |
Douglas I Buckley |
Glp-1-analoga verwendbar in der diabetesbehandlung
|
|
AU654331B2
(en)
|
1991-03-30 |
1994-11-03 |
Kissei Pharmaceutical Co. Ltd. |
Succinic acid compounds
|
|
US5155100A
(en)
|
1991-05-01 |
1992-10-13 |
Ciba-Geigy Corporation |
Phosphono/biaryl substituted dipeptide derivatives
|
|
RU2086544C1
(ru)
|
1991-06-13 |
1997-08-10 |
Хоффманн-Ля Рош АГ |
Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
|
|
DE59109151D1
(de)
|
1991-06-21 |
1999-10-14 |
Boehringer Ingelheim Pharma |
Verwendung von (s)(+)-2-äthoxy-4-[n-[1-(2-piperidino-phenyl)-3-methyl-1-butyl]aminocarbonylmethyl]-benzoesäure zur herstellung eines langzeitantidiabetikums
|
|
DE10199058I2
(de)
|
1991-07-30 |
2006-04-27 |
Alcm Co |
Kristalle von N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanin und Verfahren zu ihrer Herstellung
|
|
EP0618803A4
(en)
|
1991-12-19 |
1995-03-22 |
Southwest Found Biomed Res |
POLYPEPTIDE INHIBITING PROTEIN TRANSFER TO CHOLESTERYL ESTERS, ANTIBODIES AGAINST SYNTHETIC POLYPEPTIDE AND ANTI-ATHEROSCLEROSIS PROPHYLACTIC AND THERAPEUTIC TREATMENTS.
|
|
CA2167818A1
(en)
*
|
1993-08-02 |
1995-02-09 |
Robert George Whittaker |
Therapeutic compound - fatty acid conjugates
|
|
IL111785A0
(en)
|
1993-12-03 |
1995-01-24 |
Ferring Bv |
Dp-iv inhibitors and pharmaceutical compositions containing them
|
|
US5705483A
(en)
|
1993-12-09 |
1998-01-06 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptides, compositions and methods
|
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
|
TW313568B
(https=)
|
1994-12-20 |
1997-08-21 |
Hoffmann La Roche |
|
|
DE19616486C5
(de)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
|
TW492957B
(en)
|
1996-11-07 |
2002-07-01 |
Novartis Ag |
N-substituted 2-cyanopyrrolidnes
|
|
AU1685499A
(en)
|
1997-12-24 |
1999-07-19 |
Takeda Chemical Industries Ltd. |
Polypeptide, their production and use
|
|
WO1999043357A1
(en)
*
|
1998-02-25 |
1999-09-02 |
Micrologix Biotech Inc. |
Indolicidin and cationic peptides conjugated with polymers
|
|
GT199900147A
(es)
|
1998-09-17 |
1999-09-06 |
|
1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas.
|
|
US6197786B1
(en)
|
1998-09-17 |
2001-03-06 |
Pfizer Inc |
4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
|
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
|
US6521607B1
(en)
|
1999-09-23 |
2003-02-18 |
Pharmacia Corporation |
(R)-chiral halogenated substituted N-phenoxy N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
|
|
DE60119714T2
(de)
|
2000-03-23 |
2006-09-07 |
Takeda Chemical Industries, Ltd. |
Peptidderivat
|
|
IL152081A0
(en)
|
2000-04-12 |
2003-05-29 |
Novartis Ag |
Novel medical use of aldosterone synthase inhibitors alone or in combination with at1-receptor antagonists
|
|
US7083970B2
(en)
|
2001-04-19 |
2006-08-01 |
The Scripps Research Institute |
Methods and compositions for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs
|
|
JP5290489B2
(ja)
|
2001-11-08 |
2013-09-18 |
アッヴィ・バイオセラピューティクス・インコーポレイテッド |
Ｉｇｇ抗体の安定な液体医薬製剤
|
|
TW200407310A
(en)
|
2002-06-07 |
2004-05-16 |
Glaxo Group Ltd |
Compounds
|
|
EP1537114B8
(en)
|
2002-08-07 |
2007-10-03 |
Novartis AG |
Organic compounds as agents for the treatment of aldosterone mediated conditions
|
|
WO2004046145A1
(en)
|
2002-11-18 |
2004-06-03 |
Novartis Ag |
Imidazo[1, 5a]pyridine derivatives and methods for treating aldosterone mediated diseases
|
|
WO2004078777A2
(en)
*
|
2003-03-04 |
2004-09-16 |
Biorexis Pharmaceutical Corporation |
Dipeptidyl-peptidase protected proteins
|
|
WO2005097805A1
(en)
|
2004-03-26 |
2005-10-20 |
Eli Lilly And Company |
Compounds and methods for treating dyslipidemia
|
|
UA90269C2
(ru)
|
2004-04-02 |
2010-04-26 |
Мицубиси Танабе Фарма Корпорейшн |
Тетрагидрохинолиновые производные и способ их получения
|
|
CA2568159A1
(en)
|
2004-05-28 |
2005-12-15 |
Speedel Experimenta Ag |
Tetrahydro-imidazo [1,5-a] pyridin derivatives as aldosterone synthase inhibitors
|
|
AR050251A1
(es)
|
2004-05-28 |
2006-10-11 |
Speedel Experimenta Ag |
Compuestos heterociclicos con nitrogeno heteroatomico y composicion farmaceutica en base al compuesto
|
|
CN1997643A
(zh)
|
2004-05-28 |
2007-07-11 |
斯皮德尔实验股份公司 |
杂环化合物及其作为醛固酮合酶抑制剂的应用
|
|
TW200611897A
(en)
|
2004-07-09 |
2006-04-16 |
Speedel Experimenta Ag |
Organic compounds
|
|
TW200716105A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Imidazole compounds
|
|
TW200716634A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Heterocyclic spiro-compounds
|
|
TW200716636A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Heterocyclic spiro-compounds
|
|
GT200600381A
(es)
|
2005-08-25 |
2007-03-28 |
|
Compuestos organicos
|
|
US8673848B2
(en)
*
|
2012-01-27 |
2014-03-18 |
Novartis Ag |
Synthetic apelin mimetics for the treatment of heart failure
|
|
TW200804378A
(en)
|
2005-12-09 |
2008-01-16 |
Speedel Experimenta Ag |
Organic compounds
|
|
CN101584858A
(zh)
|
2005-12-20 |
2009-11-25 |
布里斯托尔-迈尔斯斯奎布公司 |
稳定蛋白质制剂
|
|
EP2009080A4
(en)
|
2006-04-04 |
2010-05-26 |
Taiyo Nippon Sanso Corp |
METHOD OF REMOVING METHANE, METHANE PARATOR AND METHOD USE SYSTEM
|
|
TW200808813A
(en)
|
2006-04-12 |
2008-02-16 |
Speedel Experimenta Ag |
Imidazo compounds
|
|
TW200808812A
(en)
|
2006-04-12 |
2008-02-16 |
Speedel Experimenta Ag |
Imidazo compounds
|
|
WO2007128568A1
(en)
|
2006-05-10 |
2007-11-15 |
Novartis Ag |
Bicyclic derivatives as cetp inhibitors
|
|
EP1886695A1
(en)
|
2006-06-27 |
2008-02-13 |
Speedel Experimenta AG |
Pharmaceutical combination of an aldosterone synthase inhibitor and a glucocorticoid receptor antagonist or a cortisol synthesis inhibitor or a corticotropin releasing factor antagonist
|
|
CA2657258A1
(en)
|
2006-07-20 |
2008-01-24 |
Novartis Ag |
Amino-piperidine derivatives as cetp inhibitors
|
|
JP2010501573A
(ja)
|
2006-08-25 |
2010-01-21 |
ノバルティス アクチエンゲゼルシャフト |
アルドステロン合成酵素および／または１１−β−ヒドロキシラーゼおよび／またはアロマターゼが介在する疾患の処置のための縮合イミダゾール誘導体
|
|
PE20081140A1
(es)
*
|
2006-10-25 |
2008-09-22 |
Amgen Inc |
Agentes terapeuticos a base de peptidos derivados de toxinas
|
|
EP2094680A2
(en)
|
2006-12-18 |
2009-09-02 |
Novartis AG |
Imidazoles as aldosterone synthase inhibitors
|
|
WO2008076860A1
(en)
|
2006-12-18 |
2008-06-26 |
Novartis Ag |
4-imidazolyl-1,2,3,4-tetrahydroquinoline derivatives and their use as aldosterone/11-beta-hydroxylase inhibitors
|
|
CN101578272A
(zh)
|
2006-12-18 |
2009-11-11 |
诺瓦提斯公司 |
1-取代的咪唑衍生物和它们作为醛固酮合酶抑制剂的用途
|
|
PL2134720T3
(pl)
|
2007-03-29 |
2011-04-29 |
Novartis Ag |
Heterocykliczne spiro-związki
|
|
TWI448284B
(zh)
|
2007-04-24 |
2014-08-11 |
Theravance Inc |
雙效抗高血壓劑
|
|
JP2010538071A
(ja)
|
2007-09-07 |
2010-12-09 |
セラヴァンス， インコーポレーテッド |
二重作用性降圧剤
|
|
EP2463282B1
(en)
|
2007-11-05 |
2013-08-07 |
Novartis AG |
4-Benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
|
|
MX2010006063A
(es)
|
2007-12-03 |
2010-07-01 |
Novartis Ag |
Derivados de 4-bencil-amino-pirrolidina 1,2-disustituida como inhibidores de la proteina de transferencia de colesteril-ester (cetp) utiles para el tratamiento de las enfermedades tales como hiperlipidemia o arterioesclerosis.
|
|
EP2297113A1
(en)
|
2008-04-29 |
2011-03-23 |
Theravance, Inc. |
Dual-acting antihypertensive agents
|
|
AR072297A1
(es)
|
2008-06-27 |
2010-08-18 |
Novartis Ag |
Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
|
|
KR20110039348A
(ko)
*
|
2008-08-06 |
2011-04-15 |
노보 노르디스크 헬스 케어 악티엔게젤샤프트 |
연장된 생체내 효능을 가지는 콘쥬게이트된 단백질
|
|
BRPI0919932A8
(pt)
|
2008-10-24 |
2018-02-06 |
Novartis Ag |
Pirrolina-carbóxi-lisina gerada biossinteticamente, bem como processo para preparar método para derivatizar uma proteína
|
|
CN102203117A
(zh)
*
|
2008-11-04 |
2011-09-28 |
安科治疗公司 |
Apj受体化合物
|
|
HRP20140371T1
(hr)
|
2009-05-15 |
2014-05-23 |
Novartis Ag |
Arilpiridini kao inhibitori sinteze aldosterona
|
|
CN103896796B
(zh)
|
2009-05-28 |
2016-04-27 |
诺华股份有限公司 |
作为脑啡肽酶抑制剂的取代的氨基丙酸衍生物
|
|
EP2435402B1
(en)
|
2009-05-28 |
2016-04-13 |
Novartis AG |
Substituted aminobutyric derivatives as neprilysin inhibitors
|
|
US9345661B2
(en)
|
2009-07-31 |
2016-05-24 |
Genentech, Inc. |
Subcutaneous anti-HER2 antibody formulations and uses thereof
|
|
JO2967B1
(en)
|
2009-11-20 |
2016-03-15 |
نوفارتس ايه جي |
Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
|
|
CN118767117A
(zh)
*
|
2010-01-22 |
2024-10-15 |
诺沃—诺迪斯克保健股份有限公司 |
体内功效延长的生长激素
|
|
TW201138808A
(en)
|
2010-05-03 |
2011-11-16 |
Bristol Myers Squibb Co |
Serum albumin binding molecules
|
|
WO2011143208A1
(en)
|
2010-05-13 |
2011-11-17 |
Indiana University Research And Technology Corporation |
Glucagon superfamily peptides exhibiting g protein-coupled receptor activity
|
|
AU2012229336B2
(en)
|
2011-03-11 |
2017-02-02 |
Genzyme Corporation |
Pegylated Apelin and uses thereof
|
|
CN104254540A
(zh)
*
|
2012-01-09 |
2014-12-31 |
安科治疗公司 |
Apj受体化合物
|
|
ES2875957T3
(es)
|
2012-12-20 |
2021-11-11 |
Amgen Inc |
Agonistas del receptor APJ y usos de los mismos
|
|
WO2014152955A1
(en)
|
2013-03-14 |
2014-09-25 |
Regeneron Pharmaceuticals, Inc. |
Apelin fusion proteins and uses thereof
|
|
MX2016001020A
(es)
*
|
2013-07-25 |
2016-08-03 |
Novartis Ag |
Polipeptidos ciclicos para el tratamiento de insuficiencia cardiaca.
|
|
CN105705167A
(zh)
*
|
2013-07-25 |
2016-06-22 |
诺华股份有限公司 |
合成的apelin多肽的生物缀合物
|
|
JP6803236B2
(ja)
|
2014-06-10 |
2020-12-23 |
アムジェン インコーポレイテッド |
アペリンポリペプチド
|
|
US10588980B2
(en)
|
2014-06-23 |
2020-03-17 |
Novartis Ag |
Fatty acids and their use in conjugation to biomolecules
|
|
WO2016102648A1
(en)
|
2014-12-23 |
2016-06-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Metabolically stable apelin analogs in the treatment of disease mediated by the apelin receptor
|